⌘ Services

Peptide–PNA Conjugation Services

End-to-end synthesis: PNA oligomer + peptide + site-defined conjugation

Chemically defined peptide–PNA conjugates for research workflows and delivery concepts, with controlled attachment, purification, and documentation aligned to your program stage.

Overview

Peptide–PNA conjugates are chemically defined oligonucleotide–peptide constructs in which a peptide is covalently linked to a peptide nucleic acid (PNA) oligomer. PNA is a synthetic DNA mimic with a neutral peptide-like backbone, offering strong and specific hybridization to complementary DNA or RNA while enabling diverse chemical modification strategies.

Bio-Synthesis provides peptide–PNA conjugation services as an end-to-end offering, including in-house PNA synthesis, peptide synthesis, and site-defined conjugation using chemoselective linker strategies. This integrated approach supports the generation of single, well-defined peptide–PNA conjugates suitable for reproducible research and development workflows.

Conjugation routes are selected based on handle placement, linker stability, and downstream analytical requirements, and may be performed via copper-free click chemistry, thiol-based coupling, or amide bond formation. Each conjugate is purified and analytically verified using mass spectrometry and chromatographic and/or capillary gel electrophoresis methods, with documentation aligned to the intended program stage.

Peptide–PNA conjugation services are part of our broader oligonucleotide–peptide conjugation capabilities, supporting related DNA, RNA, and antisense platforms.

PNA and Peptide Synthesis site-defined attachment Program-aligned QC ISO 9001:2015 / ISO 13485:2016 45+ Years of Expertise U.S. Facilities – Texas

Why PNA (and when peptide–PNA makes sense)

PNA backbone

neutral, peptide-like scaffold supporting strong, specific base pairing with complementary DNA/RNA

Stability concept

PNA designs are often explored for nuclease resistance and defined hybridization behavior

Conjugation value

peptides can provide targeting or CPP concepts to support cellular association while keeping a single, defined construct

Reproducibility

defined 1:1 conjugates enable clear structure–property comparisons across variants

Note: performance depends on sequence, model system, and design context; we focus on producing well-defined materials and documentation.

PNA formats we synthesize

Standard PNA

  • Custom sequences
  • Terminal handles for conjugation
  • Optional labels (program-dependent)

Functionalized PNA

  • 5′/3′ handle placement (design-dependent)
  • Azide/alkyne, thiol, amine, DBCO/BCN options
  • Spacer/PEG tuning

Specialty designs

  • Chimera-like constructs (program-dependent)
  • Multivalent/branched architectures (program-dependent)
  • Compatibility review before build

Compatibility note

Conjugation feasibility depends on the handle placement, PNA length/composition, and the desired linker strategy. If you’re unsure, send your design and constraints—we’ll recommend a practical handle + linker plan.

Custom peptide–PNA conjugate architectures

Bio-Synthesis evaluates linear and multifunctional constructs based on the required PNA sequence, peptide functionality, attachment handles and analytical feasibility. The formats below are conceptual arrangements, not fixed products.

01

Peptide–PNA

Peptide — linker — PNA

Single peptide domain paired with a sequence-specific PNA recognition domain; suitable for CPP, targeting or affinity-tag studies.

02

PNA–Peptide–PNA

PNA — linker — peptide — linker — PNA

Two PNA domains around a peptide component. Dual-handle planning, stoichiometry, solubility and purification require project-specific evaluation.

03

Peptide–PNA–Peptide

Peptide — linker — PNA — linker — peptide

Combines two peptide functionalities with a PNA domain, potentially for distinct targeting, delivery or assay roles.

04

Branched / multivalent peptide–PNA

Defined scaffold with multiple PNA or peptide arms

Custom branched constructs may be evaluated subject to steric accessibility, handle selectivity and recovery after purification.

PNA has amino/carboxyl termini rather than the sugar–phosphate 5′/3′ termini of DNA and RNA. The exact attachment position must be specified in the synthesis design.

Peptides commonly conjugated to PNA

CPP prototypes

Often used as starting points to increase cellular association (context-dependent).
  • TAT-derived peptides
  • Penetratin-derived peptides
  • Oligo-arginine (R8 / R9)
  • Transportan-related designs

For additional design guidance, see our CPP–PNA conjugate design and delivery guide.

Targeting ligands

Used to explore receptor-mediated uptake concepts (selection depends on model and goals).
  • RGD / iRGD motifs
  • Receptor-binding peptides (program-dependent)
  • Affinity/assay tags

Architectures

Options when programs require additional features.
  • Branched peptides (site-defined)
  • Spacers/PEG for sterics & solubility
  • Dual-handle constructs (program-dependent)

Peptide classes and typical research roles

Peptide class Examples Typical research use / limitation
Cell-penetrating peptides TAT-derived, penetratin, R8/R9, transportan Cellular association and uptake studies; productive cytosolic delivery and endosomal escape must be demonstrated experimentally.
Antimicrobial delivery motifs (KFF)₃K and related cationic peptides Exploratory bacterial antisense PNA delivery; organism and sequence dependent.
Receptor-targeting peptides RGD / iRGD and custom receptor-binding motifs Target recognition or uptake concepts; receptor expression and specificity require validation.
Nuclear localization motifs SV40 NLS-derived peptides Nuclear trafficking studies; does not by itself establish cell entry.
Endosomal escape motifs HA2-derived or histidine-rich sequences Investigational endosomal release strategies; efficacy and toxicity vary.
Affinity / assembly peptides His₆, biotin-bearing or other affinity motifs Nanoparticle attachment, immobilization and analytical detection; not necessarily CPPs.

These are examples from research literature and custom-design possibilities, not an inventory list or guaranteed biological performance.

Research guide: CPP–PNA conjugate design and delivery

For cell-penetrating peptide–PNA conjugates, the choice of CPP, PNA sequence, linker and cellular model can influence uptake, endosomal trapping, solubility and biological activity. Learn how to compare TAT, oligo-arginine, penetratin and other CPP approaches before selecting a construct.

Read: Cell-Penetrating Peptide–PNA Conjugates: Design and Delivery Considerations →

Linker & Conjugation Chemistry

Explore five chemistry and linker options. Select a method to see its attachment handles, strengths, design considerations, and typical applications for custom peptide–PNA conjugates.

CHEMOSELECTIVE CONJUGATION

Copper-free click chemistry

Azide–DBCO or azide–BCN coupling is a useful option for site-defined peptide–PNA assembly without adding a copper catalyst.

Azide–PNA + DBCO–Peptide → Peptide–PNA
Attachment handles

Azide and strained alkyne (DBCO or BCN), placed on complementary components.

Key advantage

Site-defined coupling with a generally straightforward byproduct profile.

Design check

Handle placement, steric accessibility, reagent stability, and purification of excess starting material.

Research fit

Defined CPP–PNA, targeting peptide–PNA, and other custom architectures.

How we choose: Bio-Synthesis reviews reactive handle compatibility, desired stability, PNA and peptide sequences, final yield, purification, and analytical QC before recommending a route. Discuss your conjugation design →

Design inputs & coupling routes (solid-phase vs solution-phase)

Design inputs we review

  • PNA: sequence/length, handle placement, polarity/solubility constraints
  • Peptide: attachment site, net charge, hydrophobicity; optional branching
  • Linker: stable vs cleavable; spacer length (PEG/alkyl) for sterics
  • Purification: route selected to separate PNA, peptide, and conjugate cleanly
  • Controls: optional PNA-only/peptide-only or matched variants

Two common coupling routes

  • Solid-phase: coupling on-support when compatible with the PNA build and handle design
  • Solution-phase: coupling purified components via click, maleimide, or amide chemistries
  • Monitoring: in-process checks can be applied to track conversion and byproducts
  • Workup: conditions selected to preserve component integrity and conjugate homogeneity

Mechanism note (CMC-safe)

Peptides used in PNA conjugates may support cellular association and uptake through multiple pathways (including receptor-mediated endocytosis for targeted ligands and other uptake routes for cationic CPPs). Design decisions (net charge, hydrophobicity, and linker architecture) are made to match the intended uptake concept while balancing stability, solubility, and analytical clarity.

For additional design guidance, see our CPP–PNA conjugate design and delivery guide.

Typical workflow

Typical workflow for peptide–PNA conjugate synthesis, purification, and analytical control

Typical workflow for peptide–PNA conjugate synthesis, conjugation, analytical QC, and final delivery.

PNA + peptide design review - confirm sequences, handle placement, and linker strategy.

PNA synthesis - build and deprotect PNA with planned functional handles.

Peptide synthesis - prepare peptide with a single defined attachment site/handle.

Site-specific conjugation - couple the prepared PNA and peptide using the selected linker chemistry.

Purification - isolate the desired peptide–PNA conjugate and remove unreacted starting materials and by-products.

Analytical QC + release - confirm identity and purity, then provide agreed documentation and final product.

QC & typical deliverables

✓
Identity
  • Mass spectrometry confirmation
  • Conjugation verification (method-appropriate)
✓
Purity
  • Chromatography and/or capillary gel electrophoresis
  • Separation from unreacted components
✓
Documentation
  • COA aligned to program stage
  • Traceable documentation package (program-dependent)

FAQ

Do you synthesize the PNA and the peptide?
Yes. We can synthesize the PNA oligomer and peptide in-house, then assemble the conjugate with site-defined chemistry. Customer-supplied components can be evaluated when specifications and handles are defined.
Which attachment sites are supported?
Common designs use N-terminus, C-terminus, or a defined side-chain handle on the peptide and terminal or internal handles on the PNA (design-dependent). We plan handle placement to reduce heterogeneity.
Which conjugation chemistry should I choose?
Copper-free click is a common default for selectivity and reproducibility. Thiol–maleimide and amide coupling are also available depending on handles and stability goals. Linkers can be stable or cleavable.
What information is needed for a quote?
Provide PNA sequence/length and desired handle placement, peptide sequence and attachment preference, preferred linker chemistry (or ask us to recommend), quantity/purity targets, and intended use.
How do I select a CPP for a PNA conjugate?
Selection depends on the target cell, PNA sequence, conjugate charge, toxicity tolerance and intracellular destination. Uptake does not guarantee functional cytosolic delivery. Read our CPP–PNA delivery design guide.
Can you synthesize PNA–peptide–PNA and other multi-domain conjugates?
 Yes. We can evaluate custom PNA–peptide–PNA, peptide–PNA–peptide and selected branched architectures. Feasibility depends on the sequences, attachment handles, linker strategy, solubility, purification and required final yield. Share your proposed design for a chemistry review.

Let's Design Your Custom Peptide–PNA Conjugate

From a simple peptide–PNA to PNA–peptide–PNA, peptide–PNA–peptide or selected branched constructs, share your research goals and specifications. Our team can review the synthesis route, linker chemistry, purification and analytical requirements.

♧
Scientific Collaboration

Discuss complex PNA sequences and custom peptide architectures.

⚗
Chemistry Development

Select linkers, reactive handles and conjugation strategies.

↗
Research-to-Therapeutic Support

Support projects from discovery through advanced development.

Custom architectures and specifications are subject to technical feasibility review. Research-use suitability and testing are defined by the project.

Partner with a Leader in Biosynthetic CDMO Solution

Partner with a Leader in
Biosynthetic CDMO Solution

Molecular design

Architectures tailored to your project

Peptide–PNA, PNA–peptide–PNA, and selected multifunctional constructs.

Design review
PNA and peptide sequences, attachment sites, spacer length and conjugate architecture.
Chemistry selection
Copper-free click, thiol–maleimide or amide coupling, selected for the design.
Feasibility
Solubility, steric access and target final yield assessed before quotation.
Analytical confidence

Purification and identity confirmation

Project-defined HPLC purification, mass spectrometry and documentation.

Purification
Chromatographic purification selected to separate conjugate from starting materials.
Identity & purity
Mass spectrometry and appropriate chromatographic analysis.
Deliverables
Agreed purity target, formulation and project-specific documentation.

Quality-Controlled Peptide–PNA Synthesis & Conjugation

A coordinated workflow for synthesis, conjugation, purification and analytical release, with project-specific documentation and traceability.

QMS ✓

ISO-Supported Quality Systems

Bio-Synthesis applies documented procedures and appropriate in-process and final analytical controls to support consistent custom peptide–PNA conjugate manufacturing.

01 ISO 9001:2015 Quality management and documented processes.
02 ISO 13485:2016 Medical-device quality management framework.
03 Traceability & Documentation Project-specific batch records and release documentation.
04 Analytical QC Mass spectrometry and HPLC or other suitable purity methods, as specified.
Quality-system certifications do not imply that every custom conjugate is manufactured under GMP. GMP-aligned project requirements should be discussed before quotation.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.